[HTML][HTML] Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Background Understanding the level and characteristics of protection from past SARS-CoV-
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other …
P Paul, A El-Naas, O Hamad, MA Salameh… - Human Vaccines & …, 2023 - Taylor & Francis
Despite widespread mass rollout programs, the rapid spread of the SARS-CoV-2 Omicron
variant called into question the effectiveness of the existing vaccines against infection …
variant called into question the effectiveness of the existing vaccines against infection …
Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants |
New England Journal of Medicine Skip to main content The New England Journal of Medicine …
New England Journal of Medicine Skip to main content The New England Journal of Medicine …
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
Abstract SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants are genetically divergent. We
conducted a matched, test-negative, case-control study to estimate duration of protection of …
conducted a matched, test-negative, case-control study to estimate duration of protection of …
Immune imprinting and protection against repeat reinfection with SARS-CoV-2
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2 | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Recall of preexisting cross-reactive B cell memory after Omicron BA. 1 breakthrough infection
Understanding immune responses after severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) breakthrough infection will facilitate the development of next-generation …
(SARS-CoV-2) breakthrough infection will facilitate the development of next-generation …
Risk of reinfection, vaccine protection, and severity of infection with the BA. 5 omicron subvariant: a nation-wide population-based study in Denmark
Background Estimates of immunity and severity for the SARS-CoV-2 omicron subvariant BA.
5 are important to assess the public health impact associated with its rapid global spread …
5 are important to assess the public health impact associated with its rapid global spread …
Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes
Importance Data about the association of COVID-19 vaccination and prior SARS-CoV-2
infection with risk of SARS-CoV-2 infection and severe COVID-19 outcomes may guide …
infection with risk of SARS-CoV-2 infection and severe COVID-19 outcomes may guide …
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Background Long-term effectiveness of COVID-19 mRNA boosters in populations with
different previous infection histories and clinical vulnerability profiles is inadequately …
different previous infection histories and clinical vulnerability profiles is inadequately …
Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with …
Background There is a paucity of data on vaccine-induced or infection-induced (hybrid or
natural) immunity against omicron (B. 1.1. 529) subvariant BA. 2, particularly in comparing …
natural) immunity against omicron (B. 1.1. 529) subvariant BA. 2, particularly in comparing …